Vaccine Expert Named First Director of Yale Institute for Global Health
Saad B. Omer, MBBS, MPH, PhD, has been named the inaugural director of the Yale Institute for Global Health (YIGH). Omer is currently the William H. Foege Professor of Global Health, Epidemiology, and Pediatrics at Emory University’s Schools of Public Health and Medicine.
How do hair follicles grow? A Yale-led study untangles the science
An outstanding question in dermatology that researchers have studied for decades is: How do hair follicles emerge from a sea of seemingly uniform skin cells during embryonic development? New research findings from a Yale-led team offer answers to that question, which may lead to strategies for regenerating lost hair follicles in adults.
New Centers to Advance Implementation and Prevention Sciences
Two new centers at the School of Medicine and the School of Public Health will promote the adoption of research findings into clinical practice and develop and assess sustainable, cost-effective interventions to improve public health domestically and around the world.
New Global Health Institute announced at Yale
The new Yale Institute for Global Health (YIGH), approved by the Yale Corporation on Dec. 8, further advances President Salovey’s goal for the university to have a greater impact on complex international issues. Led by the Schools of Medicine, Nursing, and Public Health, YIGH is a university-wide effort to address global health issues.
YCCI Beginning a Second Decade of Support
Although it is hard to believe, the Yale Center for Clinical Investigation (YCCI) is now in its second decade providing training resources and support for Yale’s clinical and translational investigators. With the second renewal of the Clinical and Translational Science Award (CTSA), YCCI is well poised to continue supporting innovative science to improve the health of patients everywhere.
Lifespan Research: Impact of Childhood Disease on Adult Health
YCCI’s renewed CTSA grant award allows Yale to continue its leadership in cutting-edge areas of research. One such novel initiative under the grant renewal is Diseases Across the Lifespan, which will explore the rising field of lifespan research — a new approach to examining the ways in which diseases that commonly strike adults have their roots in infancy and early childhood.
With the Renewal of the Yale CTSA Comes New Funding Opportunities
Yale’s status as a funded CTSA site opens several additional opportunities for external funding through National Center for Advancing Translational Sciences (NCATS). Through the NCATS’s Division of Innovation, the NIH institute and division that oversee all CTSA funding, Yale investigators can now apply for new research opportunities available only to universities with funded CTSA hubs. As part of this program, Robert Sherwin and the Yale CTSA have already been awarded three of these grants; in addition, new opportunities will continue to become available.
Blumberg honored with Colvin Prize for Outstanding Achievement in Mood Disorders Research
Hilary P. Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, Professor of Psychiatry, Radiology and Biomedical Imaging and in the Child Study Center at the Yale School of Medicine, has been awarded the Colvin Prize for Outstanding Achievement in Mood Disorders Research by the Brain & Behavior Research Foundation (BBRF).
Yale launches five-year study of origins of autism
Yale researchers will study the development of functional brain connectivity during late pregnancy to early adolescence thanks to a five-year, $12.4 million grant from Autism Centers of Excellence Program, part of efforts by the National Institutes of Health to understand the origins of autism spectrum disorders (ASD).
Lab-created mini-brains reveal how growing organ maintains neuronal balance
Scientists can now explore in a laboratory dish how the human brain develops by creating organoids — distinct, three-dimensional regions of the brain. In research published in Cell Stem Cell, Yale scientists coaxed early stage stem cells to create and fuse two types of organoids from different brain regions to show how the developing brain maintains proper balance of excitatory and inhibitory neurons.
Case report reveals successful treatment of adolescent depression with ketamine
A case report written by a team of Yale researchers describing ketamine treatment for adolescent depression is featured in April’s Journal of the American Academy of Child & Adolescent Psychiatry. The first author was Jennifer B. Dwyer, MD, PhD, Clinical Fellow in the Solnit Integrated Training Program.